Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James A Whitlock

Showing results (31-40 of 71) with videos related to

Pageof 8
Sort By:
Pediatric Blood & Cancer|June 12, 2025
Assessing the Impact of u-link.care: Implementation of a Pediatric Cancer Clinical Trials Finder Website to Improve Healthcare Provider Knowledge and Identify Barriers to EnrollmentCielle Stapleton, Ashley Doka, Lucie Pecheux, et al.
Journal of Sport Rehabilitation|May 25, 2021
Instrument-Assisted Soft Tissue Mobilization Forces Applied by Trained Clinicians During a Simulated TreatmentNickolai J P Martonick, Ashley J Reeves, James A Whitlock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 14, 2022
Efficacy and Safety of Trametinib Monotherapy or in Combination With Dabrafenib in Pediatric <i>BRAF</i> V600-Mutant Low-Grade GliomaEric Bouffet, Birgit Geoerger, Christopher Moertel, et al.
Transfusion|April 26, 2017
Optimizing autologous nonmobilized mononuclear cell collections for cellular therapy in pediatric patients with high-risk leukemiaEhud Even-Or, Maria Di Mola, Muhammad Ali, et al.
Pediatric Blood & Cancer|January 22, 2013
Phase I/II trial of clofarabine and cytarabine in children with relapsed/refractory acute lymphoblastic leukemia (AAML0523): a report from the Children's Oncology GroupTodd M Cooper, Bassem I Razzouk, Robert Gerbing, et al.
Pediatric Blood & Cancer|December 3, 2009
Working memory in survivors of childhood acute lymphocytic leukemia: functional neuroimaging analysesKristen E Robinson, Katherine L Livesay, Laura K Campbell, et al.
BMC Palliative Care|January 29, 2016
Protocol: Evaluating the impact of a nation-wide train-the-trainer educational initiative to enhance the quality of palliative care for children with cancerKimberley Widger, Stefan Friedrichsdorf, Joanne Wolfe, et al.
British Journal of Haematology|March 16, 2017
A phase 1 trial of temsirolimus and intensive re-induction chemotherapy for 2nd or greater relapse of acute lymphoblastic leukaemia: a Children's Oncology Group study (ADVL1114)Susan R Rheingold, Sarah K Tasian, James A Whitlock, et al.
British Journal of Haematology|April 9, 2019
Bortezomib reinduction chemotherapy in high-risk ALL in first relapse: a report from the Children's Oncology GroupTerzah M Horton, James A Whitlock, Xiaomin Lu, et al.
Journal of Palliative Medicine|May 22, 2018
National Impact of the EPEC-Pediatrics Enhanced Train-the-Trainer Model for Delivering Education on Pediatric Palliative CareKimberley Widger, Joanne Wolfe, Stefan Friedrichsdorf, et al.
Pageof 8

Showing results (31-40 of 71) with videos related to

Sort By:
Pageof 8
Pediatric Blood & Cancer|June 12, 2025
Assessing the Impact of u-link.care: Implementation of a Pediatric Cancer Clinical Trials Finder Website to Improve Healthcare Provider Knowledge and Identify Barriers to EnrollmentCielle Stapleton, Ashley Doka, Lucie Pecheux, et al.
Journal of Sport Rehabilitation|May 25, 2021
Instrument-Assisted Soft Tissue Mobilization Forces Applied by Trained Clinicians During a Simulated TreatmentNickolai J P Martonick, Ashley J Reeves, James A Whitlock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 14, 2022
Efficacy and Safety of Trametinib Monotherapy or in Combination With Dabrafenib in Pediatric <i>BRAF</i> V600-Mutant Low-Grade GliomaEric Bouffet, Birgit Geoerger, Christopher Moertel, et al.
Transfusion|April 26, 2017
Optimizing autologous nonmobilized mononuclear cell collections for cellular therapy in pediatric patients with high-risk leukemiaEhud Even-Or, Maria Di Mola, Muhammad Ali, et al.
Pediatric Blood & Cancer|January 22, 2013
Phase I/II trial of clofarabine and cytarabine in children with relapsed/refractory acute lymphoblastic leukemia (AAML0523): a report from the Children's Oncology GroupTodd M Cooper, Bassem I Razzouk, Robert Gerbing, et al.
Pediatric Blood & Cancer|December 3, 2009
Working memory in survivors of childhood acute lymphocytic leukemia: functional neuroimaging analysesKristen E Robinson, Katherine L Livesay, Laura K Campbell, et al.
BMC Palliative Care|January 29, 2016
Protocol: Evaluating the impact of a nation-wide train-the-trainer educational initiative to enhance the quality of palliative care for children with cancerKimberley Widger, Stefan Friedrichsdorf, Joanne Wolfe, et al.
British Journal of Haematology|March 16, 2017
A phase 1 trial of temsirolimus and intensive re-induction chemotherapy for 2nd or greater relapse of acute lymphoblastic leukaemia: a Children's Oncology Group study (ADVL1114)Susan R Rheingold, Sarah K Tasian, James A Whitlock, et al.
British Journal of Haematology|April 9, 2019
Bortezomib reinduction chemotherapy in high-risk ALL in first relapse: a report from the Children's Oncology GroupTerzah M Horton, James A Whitlock, Xiaomin Lu, et al.
Journal of Palliative Medicine|May 22, 2018
National Impact of the EPEC-Pediatrics Enhanced Train-the-Trainer Model for Delivering Education on Pediatric Palliative CareKimberley Widger, Joanne Wolfe, Stefan Friedrichsdorf, et al.
Pageof 8